Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Joel A Yates"'
Autor:
Megan A Altemus, Laura E Goo, Andrew C Little, Joel A Yates, Hannah G Cheriyan, Zhi Fen Wu, Sofia D Merajver
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0220973 (2019)
In breast cancer, tumor hypoxia has been linked to poor prognosis and increased metastasis. Hypoxia activates transcriptional programs in cancer cells that lead to increased motility and invasion, as well as various metabolic changes. One of these me
Externí odkaz:
https://doaj.org/article/6e2faa1d21d44102b6ad4e9a6cfac013
Autor:
Anbarasu Kumaraswamy, Zhi Duan, Diana Flores, Chao Zhang, Archana Sehrawat, Ya-Mei Hu, Olivia A. Swaim, Eva Rodansky, William K. Storck, Joshua A. Kuleape, Karan Bedi, Rahul Mannan, Xiao-Ming Wang, Aaron Udager, Visweswaran Ravikumar, Armand Bankhead III, Ilsa Coleman, John K. Lee, Colm Morrissey, Peter S. Nelson, Arul M. Chinnaiyan, Arvind Rao, Zheng Xia, Joel A. Yates, Joshi J. Alumkal
Publikováno v:
JCI Insight, Vol 8, Iss 15 (2023)
Lysine-specific demethylase 1 (LSD1) is a histone demethylase that promotes stemness and cell survival in cancers such as prostate cancer. Most prostate malignancies are adenocarcinomas with luminal differentiation. However, some tumors undergo cellu
Externí odkaz:
https://doaj.org/article/e4a07a2910524a9eab732b3ab8ace38b
Autor:
Trisha M. Westerhof, Benjamin A. Yang, Nathan M. Merrill, Joel A. Yates, Megan Altemus, Liam Russell, Anna J. Miller, Liwei Bao, Zhifen Wu, Peter J. Ulintz, Carlos A. Aguilar, Aki Morikawa, Maria G. Castro, Sofia D. Merajver, Christopher R. Oliver
Publikováno v:
Advanced NanoBiomed Research, Vol 3, Iss 8, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/87947428f0654eeab189f5ee0a14f82f
Autor:
William K. Storck, Allison M. May, Thomas C. Westbrook, Zhi Duan, Colm Morrissey, Joel A. Yates, Joshi J. Alumkal
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
The androgen receptor (AR) signaling pathway is critical for growth and differentiation of prostate cancer cells. For that reason, androgen deprivation therapy with medical or surgical castration is the principal treatment for metastatic prostate can
Externí odkaz:
https://doaj.org/article/8696175c54894aefa79197c1c53aecc8
Autor:
Daniel J. Coleman, David A. Sampson, Archana Sehrawat, Anbarasu Kumaraswamy, Duanchen Sun, Yuzhuo Wang, Jacob Schwartzman, Joshua Urrutia, Ahn R. Lee, Ilsa M. Coleman, Peter S. Nelson, Xuesen Dong, Colm Morrissey, Eva Corey, Zheng Xia, Joel A. Yates, Joshi J. Alumkal
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 22, Iss 6, Pp 253-262 (2020)
Neuroendocrine prostate cancer (NEPC) is the most virulent form of prostate cancer. Importantly, our recent work examining metastatic biopsy samples demonstrates NEPC is increasing in frequency. In contrast to prostate adenocarcinomas that express a
Externí odkaz:
https://doaj.org/article/d5b944dbbb4c47a8814fa347edf364fc
Autor:
Andrew C. Little, Pragathi Pathanjeli, Zhifen Wu, Liwei Bao, Laura E. Goo, Joel A. Yates, C. Ryan Oliver, Matthew B. Soellner, Sofia D. Merajver
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Tumor associated macrophages (TAMs) are increasingly recognized as major contributors to the metastatic progression of breast cancer and enriched levels of TAMs often correlate with poor prognosis. Despite our current advances it remains unclear whic
Externí odkaz:
https://doaj.org/article/d0ba3a24fe7641e084834f4fbb5997a7
Autor:
Joshi J. Alumkal, Zheng Xia, Joel A. Yates, Eric Campeau, Sanjay Lakhotia, Sarah Attwell, Emily M. Gesner, Arvind Rao, Armand Bankhead, Daniel E. Spratt, Eric J. Small, Felix Y. Feng, Wassim Abida, Rahul Aggarwal, Jonathan Z. Sexton, Samuel K. Handelman, Eva Corey, Peter S. Nelson, Ilsa M. Coleman, Jared M. Lucas, Colm Morrissey, Mark P. Labrecque, Himisha Beltran, Chao Zhang, Jacob A. Schwartzman, Joshua A. Urrutia, Eva S. Rodansky, Anbarasu Kumaraswamy, Xiangnan Guan, David Sampson, Daniel J. Coleman, Chelsea Jenkins, Katherine Welker Leng, William K. Storck, Duanchen Sun, Dae-Hwan Kim
Supplementary Table S5 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184f8ddc3a8bdce5db61ce2644baf9fd
https://doi.org/10.1158/1078-0432.22481639
https://doi.org/10.1158/1078-0432.22481639
Autor:
Joshi J. Alumkal, Zheng Xia, Joel A. Yates, Eric Campeau, Sanjay Lakhotia, Sarah Attwell, Emily M. Gesner, Arvind Rao, Armand Bankhead, Daniel E. Spratt, Eric J. Small, Felix Y. Feng, Wassim Abida, Rahul Aggarwal, Jonathan Z. Sexton, Samuel K. Handelman, Eva Corey, Peter S. Nelson, Ilsa M. Coleman, Jared M. Lucas, Colm Morrissey, Mark P. Labrecque, Himisha Beltran, Chao Zhang, Jacob A. Schwartzman, Joshua A. Urrutia, Eva S. Rodansky, Anbarasu Kumaraswamy, Xiangnan Guan, David Sampson, Daniel J. Coleman, Chelsea Jenkins, Katherine Welker Leng, William K. Storck, Duanchen Sun, Dae-Hwan Kim
Supplementary Figure S3 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::380d5df6f1565ca06f349c5d1c89338e
https://doi.org/10.1158/1078-0432.22481663.v1
https://doi.org/10.1158/1078-0432.22481663.v1
Autor:
Joshi J. Alumkal, Zheng Xia, Joel A. Yates, Eric Campeau, Sanjay Lakhotia, Sarah Attwell, Emily M. Gesner, Arvind Rao, Armand Bankhead, Daniel E. Spratt, Eric J. Small, Felix Y. Feng, Wassim Abida, Rahul Aggarwal, Jonathan Z. Sexton, Samuel K. Handelman, Eva Corey, Peter S. Nelson, Ilsa M. Coleman, Jared M. Lucas, Colm Morrissey, Mark P. Labrecque, Himisha Beltran, Chao Zhang, Jacob A. Schwartzman, Joshua A. Urrutia, Eva S. Rodansky, Anbarasu Kumaraswamy, Xiangnan Guan, David Sampson, Daniel J. Coleman, Chelsea Jenkins, Katherine Welker Leng, William K. Storck, Duanchen Sun, Dae-Hwan Kim
Supplementary Data from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212ea32b543bc433b2e2d94d66815153
https://doi.org/10.1158/1078-0432.22481681
https://doi.org/10.1158/1078-0432.22481681
Autor:
Joshi J. Alumkal, Zheng Xia, Joel A. Yates, Eric Campeau, Sanjay Lakhotia, Sarah Attwell, Emily M. Gesner, Arvind Rao, Armand Bankhead, Daniel E. Spratt, Eric J. Small, Felix Y. Feng, Wassim Abida, Rahul Aggarwal, Jonathan Z. Sexton, Samuel K. Handelman, Eva Corey, Peter S. Nelson, Ilsa M. Coleman, Jared M. Lucas, Colm Morrissey, Mark P. Labrecque, Himisha Beltran, Chao Zhang, Jacob A. Schwartzman, Joshua A. Urrutia, Eva S. Rodansky, Anbarasu Kumaraswamy, Xiangnan Guan, David Sampson, Daniel J. Coleman, Chelsea Jenkins, Katherine Welker Leng, William K. Storck, Duanchen Sun, Dae-Hwan Kim
Supplementary Table S2 S4 S6 S7 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16078ca74f4249c0affafe9aadcfadc3
https://doi.org/10.1158/1078-0432.22481645.v1
https://doi.org/10.1158/1078-0432.22481645.v1